Pembrolizumab is a programmed death receptor-1 (PD-1)-blocking antibody indicated for:
- Melanoma
- Non-Small Cell Lung Cancer (NSCLC)
- Small Cell Lung Cancer (SCLC)
- Head and Neck Squamous Cell Cancer (HNSCC):
- Classical Hodgkin Lymphoma (cHL)
- Primary Mediastinal Large B-Cell Lymphoma (PMBCL)
- Urothelial Carcinoma:
- Microsatellite Instability-High Cancer
- Gastric Cancer
- Esophageal Cancer
- Cervical Cancer
- Hepatocellular Carcinoma (HCC)
- Merkel Cell Carcinoma (MCC)
- Renal Cell Carcinoma (RCC)
- Endometrial Carcinoma
Description
XYZ is a programmed death receptor-1 (PD 1)-blocking antibody.
Features
| Generics | XYZ |
| Strength | XYZ |